AABME MENU
AABME
Knowledge Login
  • Knowledge
  • About
  • Biotech & Pharma
    • Cell Therapy
    • Bionanotechnology
    • Advanced Drug Delivery
  • Key Technologies
    • Artificial Organs
    • 3D Bioprinting
    • Enhancement Prosthetics
    • Robotics
    • Advanced Materials
    • Augmented and Virtual Reality
    • Implants
    • Tissue-engineered organ replacements
    • Microbiome Technologies
    • Big Data Analytics
    • Biomanufacturing
  • Medical Devices
    • Monitoring
    • Imaging
    • Ultrasound and MRI
    • External Neurostimulators
    • Wearables, Embedded, Bioprinted Sensors
    • Diagnostic
  • Publications
  • Standards
  • Events
  • Learning
    AABME
  • Knowledge
  • About
  • Biotech & Pharma
    • Cell Therapy
    • Bionanotechnology
    • Advanced Drug Delivery
  • Key Technologies
    • Artificial Organs
    • 3D Bioprinting
    • Enhancement Prosthetics
    • Robotics
    • Advanced Materials
    • Augmented and Virtual Reality
    • Implants
    • Tissue-engineered organ replacements
    • Microbiome Technologies
    • Big Data Analytics
    • Biomanufacturing
  • Medical Devices
    • Monitoring
    • Imaging
    • Ultrasound and MRI
    • External Neurostimulators
    • Wearables, Embedded, Bioprinted Sensors
    • Diagnostic
  • Publications
  • Standards
  • Events
  • Learning
  • Login

Browse or choose a topic of interest:

  • Key Technologies
  • Artificial Organs
  • 3D Bioprinting
  • Enhancement Prosthetics
  • Robotics
  • Advanced Materials
  • Augmented and Virtual Reality
  • Implants
  • Tissue-engineered organ replacements
  • Microbiome Technologies
  • Big Data Analytics
  • Biomanufacturing

Microbiome Technologies

Mini Guts Could Improve Personalized Therapy Production

Researchers use minibioreactor arrays to study the gut, coupling them with high-throughput screening techniques to examine the effects of different therapies on digestive system diseases. Reported by AABME.org

Melissa Lutz Blouin
April 02, 2018
Imaging, Biomarkers, and Cancer

The landscape is constantly evolving for imaging technology and biomarkers, and how they impact cancer detection and treatment. Frost & Sullivan has provided AABME with market intelligence on key innovations for imaging and biomarker technology for oncology.

August 12, 2017
Access Premium Content for Free

Gain access to free tools and resources from AABME, an initiative designed to stimulate biomedical innovation by bringing together and providing resources to the biomedical engineering community.

Harnessing Microbiome Science for Therapeutic Development

In the era of personalized medicine, the microbiome industry’s growth trajectory parallels that of genomics in the early 2000s. According to Frost & Sullivan, the global demand for more effective medicines and healthier nutrition will continue to drive the development of microbiomic products. Here are the latest trends.

July 12, 2017
  • Home
  • About AABME
  • Contact
  • Join the Alliance
  • Terms of Use
  • Privacy Statement
  • Community Rules
© 2019 The American Society of Mechanical Engineers. All rights reserved.